What Are The Side Effects Of Immunotherapy?

Shortness Of Breath

Shortness of breath, or dyspnea, is a potential side effect of immunotherapy, particularly in patients receiving treatment for lung cancer. Immunotherapy intensifies immune system reactions not only against cancer cells but also towards healthy tissues, including lung tissues. This immune activation can manifest as pneumonitis, leading to inflammation in the lungs and compromising respiratory function. Symptoms such as coughing, wheezing, and frequent shortness of breath may result from the inflammation-induced narrowing of airways and obstruction of air sacs. Recognizing the connection between immune activation and respiratory symptoms guides effective management strategies, ensuring optimal patient outcomes.

Managing shortness of breath necessitates a multidimensional approach, involving close monitoring of respiratory function, prompt intervention in case of symptoms, and collaboration between healthcare providers to tailor treatment plans. Educating patients about potential respiratory side effects empowers them to actively participate in their care.